Skip to main content
. Author manuscript; available in PMC: 2016 Jul 31.
Published in final edited form as: Vaccine. 2015 Jun 10;33(32):4019–4024. doi: 10.1016/j.vaccine.2015.05.092

Table 1.

Coverage with hepatitis B vaccine in Tajikistan, 2002–2012 [2022].

Year Age in 2010 (years)a Birth dose administrative coverage (%) 3-dose coverage (%)
Administrative WHO/UNICEF estimate
2002 8 80 39 39
2003 7 77 60 58
2004b 6 90 85 81
2005 5 98 93 81
2006 4 94 94 88
2007 3 83 84 84
2008 2 85 86 86
2009 1 97 93 93
2010 96 93 93
2011c 98 96 96
2012 98 94 94
a

Applicable only to birth cohorts included in the serosurvey (2002–2009).

b

Coverage for 2004 birth cohort in 2005 Multiple Indicator Cluster Survey (MICS): HepB1—85%, HepB2—77%, HepB3—69%.

c

Coverage for 2011 birth cohort in 2012 Demographic and Health Survey (DHS): birth dose—93%, Penta1—98%, Penta2—96%, Penta3—93%.